insulin glargine   Click here for help

GtoPdb Ligand ID: 7572

Synonyms: HOE-901 | HOE901 | Lantus®
Approved drug
insulin glargine is an approved drug (FDA and EMA (2000))
Comment: Insulin glargine is a recombinant, modified analogue of human insulin. A fixed-ratio formulation containing insulin glargine and lixisenatide is being assessed in clinical trials for the treatment of type 2 diabetes. Click here to view a list of such trials registered with ClinicalTrials.gov.

Biosimilar drugs: Insulin glargine biosimilar SB9 is in development by Samsung Bioepis
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: glargine

Classification Click here for help
Compound class Peptide or derivative
Approved drug? Yes (FDA and EMA (2000))
International Nonproprietary Names Click here for help
INN number INN
7548 insulin glargine
Synonyms Click here for help
HOE-901 | HOE901 | Lantus®
Database Links Click here for help
CAS Registry No. 160337-95-1
ChEMBL Ligand CHEMBL1201497
DrugBank Ligand DB00047
GtoPdb PubChem SID 223365908
PubChem CID 44146714
Search PubMed clinical trials insulin glargine
Search PubMed titles insulin glargine
Search PubMed titles/abstracts insulin glargine
Wikipedia Insulin glargine